Navigation Links
Bledsoe Extender Arm Brace

ProductsBledsoe Extender Arm Brace
Company Bledsoe Brace Systems
Item Bledsoe Extender Arm Brace
Features 
  • Formable aluminum plates adjust to fit virtually any arm circumference.
  • After initial fitting, the brace can be easily removed in one piece and reapplied by the patient with one hand.
  • Open, light weight design for patient comfort. The lateral hinge and arm design prevents rubbing against the body or abrasions.
  • Hinge is quick setting and limits extension from 0 to 90, flexion from 0 to 135, and locks 0 to 90 in 15 increments.
  • Detachable, formable wristarm splint for increased
  • stability of the forearm-wrist-hand.
    • Description The Bledsoe Extender Arm Brace is designed to handle post-op elbow arthroscopy, severe elbow strains and ligament trauma. The Bledsoe Extender Arm Brace should be used when limited R.O.M. or locked control of the elbow is desired. In most cases, the Bledsoe Extender Arm Brace can be formed, fitted and adjusted in 5 minutes or less.
    Info Bledsoe Brace Systems
    Customer Service: (888) 253-3763
    Web site: http://www.bledsoebrace.com/

    Related medicine products :

    1. Bledsoe Achilles Boot
    2. Bledsoe Breeze Boot
    3. Bledsoe Conformer Boot
    4. Bledsoe Flatform Boot
    5. Bledsoe Hi-Top Boot
    6. Bledsoe Low Cost Boot
    7. Bledsoe Lo-Top Boot
    8. Bledsoe Mid-Calf Boot
    9. Bledsoe Short Term Boot
    10. Bledsoe PTB Boot
    11. Bledsoe Tenderfoot Boot
    All USIOL lenses are manufactured using the highest quality materials and processes. Perspex CQ UV PMMA material is used in the multi-piece and single piece lenses. Unioptic lens models are available
    Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia.
    1% Sodium Hyaluronate, 10mg/mL, sterile opthalmic injection
    ...ptimum molecular weight and viscosity, so that it ...cts the delicate structures of the eye. , ,Ray...and pseudoplasticity to satisfy all the requiremen...phthalmic viscoelastic device. , ,Combine thes...
    Medicine Products:
    (Date:5/16/2008)...TER, Minn., May 16 /PRNewswire-USNewswire/ -- This...y Mayo Clinic in conjunction with the,National Can...study being presented at the American Society of C...0), may change treatment practice,in about 25 perc... for,proposed changes to the way colorectal cancer...
    (Date:5/16/2008)...udy being presented at the American Society of Cli..., may change treatment practice in about 25 percen...or proposed changes to the way colorectal cancers ...al Cancer Institute (NCI) SEER population-based st...I clinical trial data, shows that outcomes of pati...
    (Date:5/16/2008)...ton) Declaring that Primary care medicine is in a...sident of the American College of Physicians (ACP)...ployers and consumers to issue a call for comprehe...al internists and other primary care physicians. ...ary care medicine in the U.S., Dr. Dale and other ...
    (Date:5/16/2008)...to Save Vital Services for Frail Seniors and Peopl...ewswire-USNewswire/ -- Thousands of,homecare worke...hwarzenegger,s proposed cuts to hours of service, ...fornia,s most vulnerable workers and the,people th... these vital,services for seniors and people with ...
    Breaking Medicine News(10 mins):Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2
    ...g children than they do to cause it, new research ...e of obesity// rose more than twice as fast when k...r vacation than when they were in school. And obe...in school: they gained weight no faster than other...
    ...elp, negative social reactions may increase the ps...a University of Illinois at Chicago study. The st... Women Quarterly, found negative reactions that vi...could lead to avoidance coping, self-blame and pos...
    ...ts in Britain have come under a scanner due to a r...al of the American Medical Association. According...a prolonged period may actually increase the morta...mper the chances of conceiving in women. The resea...
    ...ermarket were found to contain salt levels hazardo...lt and Health (Cash). A study surveyed 138 loaves... Food Standards Agency's guideline maximum level. ...ntained salt levels above the Government's maxm. o...
    Other Medicine News:Health News:Schools Help Hold the Line Against Childhood Obesity 2Health News:Schools Help Hold the Line Against Childhood Obesity 3Health News:Study Examines Negative Reactions to Sexual Assault Victims 2Health News:Too Much of Salt in Bread.. 2
    (Date:5/15/2008)...ks, Hispanics/Latinos, People wit...., May 15 /- Daiichi Sankyo, Inc.,an...Society of,Hypertension,s Twenty- Third Annual Sci...ated that the powerful combination drug AZOR(TM),(...fectively helped,patients across several major sub...
    (Date:5/15/2008)...ared device to identify the, lipid core (fatty) c...th complications of coronary ste...InfraReDx, Inc. today,announced that physicians at...ssfully used its LipiScan(TM) Coronary Imaging Sys...ion. This is the first patient in the,world in who...
    (Date:5/15/2008).../ -- Ergonex Pharma today,announced that the Unite...anted orphan drug designation to Terguride for the...). Terguride is currently being evaluated for PAH,...s grant of orphan drug designation to Terguride fo...rogram by offering regulatory,clinical developmen...
    (Date:5/15/2008)...-- Tigris Pharmaceuticals,Inc. announced today th...ent Agreement (CRADA) with the National Cancer Ins...nical development of AFP-464, an,aminoflavone curr... to,metabolites which bind covalently to DNA, resu...art of a four-year CRADA encompassing multiple Pha...
    Breaking Medicine Technology:Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Assurant Health Gains Access to Great West Healthcares Nationwide Network 9501 1Assurant Health Gains Access to Great West Healthcares Nationwide Network 9501 2Assurant Health Gains Access to Great West Healthcares Nationwide Network 9501 3Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA based Diagnostics for Brain Cancer 2576 1Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA based Diagnostics for Brain Cancer 2576 2Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA based Diagnostics for Brain Cancer 2576 3Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA based Diagnostics for Brain Cancer 2576 4Woodbridge Offers the Broadest Range of BioFoam 28TM 29 Green Polyurethane Automotive Interior Applications 2572 1Woodbridge Offers the Broadest Range of BioFoam 28TM 29 Green Polyurethane Automotive Interior Applications 2572 2FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 1FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 2FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 3
    ...LONA, Spain, May 22, 2007 /PRNewswire/ -- Principa... STent with,Antiproliferative for Restenosis) tria...mium paclitaxel-eluting coronary stent,presented ...uroPCR,2007. The investigators confirmed that the ...reviously announced this conclusion in a,press rel...
    ...able Stent Continues to Show Promise as Future-Gen... /PRNewswire-FirstCall/ -- Abbott,today announced ...inical trial evaluating the safety and performance...orm for the treatment of,coronary artery disease. ...he trial, presented today at the EuroPCR meeting,...
    Other Medicine Technology:Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 2Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 3Abbott Announces Positive Nine-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2Abbott Announces Positive Nine-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3